Michael Oredsson has 30 years’ experience in senior roles in Life Science and FMCG, including more than 20 years as CEO in listed and private companies.
During that period, he also served as chairman and held board positions in a number of life science companies. Before joining A-Mansia, Michael held notable positions as CEO of probiotics company Probi and biotech company BioInvent, both listed on Nasdaq Stockholm.
He is a native of Sweden but has worked internationally throughout his career. As such, he is uniquely qualified to lead A-Mansia in the next phase of its growth as the company prepares for commercialization of its Akkermansia based products.